Clinical Trial Update: RICE: Radio-Immuno-Chemotherapy of Cancer of the Esophagus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on RICE (Radio-Immuno-Chemotherapy) for esophageal adenocarcinoma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma

Snippet

Sponsor: University of Cologne | Conditions: Esophageal Adenocarcinoma | Phase 2 | Status: UNKNOWN